Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Hepatic Antiviral Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Hepatic Antiviral Drugmarket, defines the market attractiveness level of Hepatic Antiviral Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Hepatic Antiviral Drug industry, describes the types of Hepatic Antiviral Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hepatic Antiviral Drug market and the development prospects and opportunities of Hepatic Antiviral Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hepatic Antiviral Drug market in Chapter 13.
By Player:
Prinston Pharmaceutical
Zydus Cadila
Teva Pharmaceutical Industries
Hetero Drug
Bristol-Myers Squibb
Aurobindo Pharma
Gilead Sciences
Cipla
Mylan
Apotex
By Type:
Entecavir
Tenofovir
lamivudine
Adefovir
Telbivudine
Others
By End-User:
Hospitals
Homecare
Clinics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Hepatic Antiviral Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Hepatic Antiviral Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Hepatic Antiviral Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Hepatic Antiviral Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Hepatic Antiviral Drug Market Analysis and Outlook to 2022
-
7.1 Global Hepatic Antiviral Drug Consumption (2017-2022)
-
7.2 United States Hepatic Antiviral Drug Consumption (2017-2022)
-
7.3 Europe Hepatic Antiviral Drug Consumption (2017-2022)
-
7.4 China Hepatic Antiviral Drug Consumption (2017-2022)
-
7.5 Japan Hepatic Antiviral Drug Consumption (2017-2022)
-
7.6 India Hepatic Antiviral Drug Consumption (2017-2022)
-
7.7 South Korea Hepatic Antiviral Drug Consumption (2017-2022)
8 Region and Country-wise Hepatic Antiviral Drug Market Analysis and Outlook to 2028
-
8.1 Global Hepatic Antiviral Drug Consumption Forecast (2022-2028)
-
8.2 United States Hepatic Antiviral Drug Consumption Forecast (2022-2028)
-
8.3 Europe Hepatic Antiviral Drug Consumption Forecast (2022-2028)
-
8.4 China Hepatic Antiviral Drug Consumption Forecast (2022-2028)
-
8.5 Japan Hepatic Antiviral Drug Consumption Forecast (2022-2028)
-
8.6 India Hepatic Antiviral Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Hepatic Antiviral Drug Consumption Forecast (2022-2028)
9 Global Hepatic Antiviral Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Hepatic Antiviral Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Entecavir Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Tenofovir Consumption and Growth Rate (2017-2022)
-
9.1.3 Global lamivudine Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Adefovir Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Telbivudine Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Hepatic Antiviral Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Homecare Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Hepatic Antiviral Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Hepatic Antiviral Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Entecavir Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Tenofovir Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global lamivudine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Adefovir Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Telbivudine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Hepatic Antiviral Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Homecare Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Hepatic Antiviral Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Hepatic Antiviral Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Hepatic Antiviral Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Hepatic Antiviral Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Hepatic Antiviral Drug Market Competitive Analysis
-
14.1 Prinston Pharmaceutical
-
14.1.1 Prinston Pharmaceutical Company Details
-
14.1.2 Prinston Pharmaceutical Hepatic Antiviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Prinston Pharmaceutical Hepatic Antiviral Drug Product and Service
-
14.2 Zydus Cadila
-
14.2.1 Zydus Cadila Company Details
-
14.2.2 Zydus Cadila Hepatic Antiviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Zydus Cadila Hepatic Antiviral Drug Product and Service
-
14.3 Teva Pharmaceutical Industries
-
14.3.1 Teva Pharmaceutical Industries Company Details
-
14.3.2 Teva Pharmaceutical Industries Hepatic Antiviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Teva Pharmaceutical Industries Hepatic Antiviral Drug Product and Service
-
14.4 Hetero Drug
-
14.4.1 Hetero Drug Company Details
-
14.4.2 Hetero Drug Hepatic Antiviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Hetero Drug Hepatic Antiviral Drug Product and Service
-
14.5 Bristol-Myers Squibb
-
14.5.1 Bristol-Myers Squibb Company Details
-
14.5.2 Bristol-Myers Squibb Hepatic Antiviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bristol-Myers Squibb Hepatic Antiviral Drug Product and Service
-
14.6 Aurobindo Pharma
-
14.6.1 Aurobindo Pharma Company Details
-
14.6.2 Aurobindo Pharma Hepatic Antiviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Aurobindo Pharma Hepatic Antiviral Drug Product and Service
-
14.7 Gilead Sciences
-
14.7.1 Gilead Sciences Company Details
-
14.7.2 Gilead Sciences Hepatic Antiviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Gilead Sciences Hepatic Antiviral Drug Product and Service
-
14.8 Cipla
-
14.8.1 Cipla Company Details
-
14.8.2 Cipla Hepatic Antiviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Cipla Hepatic Antiviral Drug Product and Service
-
14.9 Mylan
-
14.9.1 Mylan Company Details
-
14.9.2 Mylan Hepatic Antiviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Mylan Hepatic Antiviral Drug Product and Service
-
14.10 Apotex
-
14.10.1 Apotex Company Details
-
14.10.2 Apotex Hepatic Antiviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Apotex Hepatic Antiviral Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Hepatic Antiviral Drug
-
Figure Hepatic Antiviral Drug Picture
-
Table Global Hepatic Antiviral Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hepatic Antiviral Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hepatic Antiviral Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Hepatic Antiviral Drug Consumption by Country (2017-2022)
-
Figure United States Hepatic Antiviral Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Hepatic Antiviral Drug Consumption and Growth Rate (2017-2022)
-
Figure China Hepatic Antiviral Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Hepatic Antiviral Drug Consumption and Growth Rate (2017-2022)
-
Figure India Hepatic Antiviral Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Hepatic Antiviral Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatic Antiviral Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Hepatic Antiviral Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Hepatic Antiviral Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Hepatic Antiviral Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Hepatic Antiviral Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Hepatic Antiviral Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Hepatic Antiviral Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Entecavir Consumption and Growth Rate (2017-2022)
-
Figure Global Tenofovir Consumption and Growth Rate (2017-2022)
-
Figure Global lamivudine Consumption and Growth Rate (2017-2022)
-
Figure Global Adefovir Consumption and Growth Rate (2017-2022)
-
Figure Global Telbivudine Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Homecare Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Entecavir Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tenofovir Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global lamivudine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adefovir Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Telbivudine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Homecare Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Hepatic Antiviral Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Hepatic Antiviral Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Prinston Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Prinston Pharmaceutical Hepatic Antiviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Prinston Pharmaceutical Hepatic Antiviral Drug Product and Service
-
Table Zydus Cadila (Foundation Year, Company Profile and etc.)
-
Table Zydus Cadila Hepatic Antiviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zydus Cadila Hepatic Antiviral Drug Product and Service
-
Table Teva Pharmaceutical Industries (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Hepatic Antiviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Hepatic Antiviral Drug Product and Service
-
Table Hetero Drug (Foundation Year, Company Profile and etc.)
-
Table Hetero Drug Hepatic Antiviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hetero Drug Hepatic Antiviral Drug Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Hepatic Antiviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Hepatic Antiviral Drug Product and Service
-
Table Aurobindo Pharma (Foundation Year, Company Profile and etc.)
-
Table Aurobindo Pharma Hepatic Antiviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aurobindo Pharma Hepatic Antiviral Drug Product and Service
-
Table Gilead Sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Hepatic Antiviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Hepatic Antiviral Drug Product and Service
-
Table Cipla (Foundation Year, Company Profile and etc.)
-
Table Cipla Hepatic Antiviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla Hepatic Antiviral Drug Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Hepatic Antiviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Hepatic Antiviral Drug Product and Service
-
Table Apotex (Foundation Year, Company Profile and etc.)
-
Table Apotex Hepatic Antiviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Apotex Hepatic Antiviral Drug Product and Service
-
